Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marissa Barbaro

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2023
Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial MeningiomaSylvia C Kurz, Elcin Zan, Christine Cordova, et al.
Journal of Neurosurgery. Case Lessons|July 20, 2022
[68Ga]-DOTATATE PET/CT and PET/MRI in the diagnosis and management of esthesioneuroblastoma: illustrative casesMichelle Roytman, Andrew B Tassler, Ashutosh Kacker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2024
T2-FLAIR Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B Status in IDH-Mutant AstrocytomasMatthew D Lee, Rajan Jain, Kristyn Galbraith, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 28, 2025
Neoadjuvant PD1 blockade with laser interstitial thermal therapy for recurrent high-grade gliomaCarter M Suryadevara, Hayley Donaldson, Hammad A Khan, et al.
BMC Genomics|June 1, 2012
Identification of chemosensory receptor genes in Manduca sexta and knockdown by RNA interferenceNatalie Howlett, Katherine L Dauber, Aditi Shukla, et al.
Neuro-Oncology|January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomasKristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
Molecular Cancer Research : MCR|October 23, 2023
Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain TumorsKristyn Galbraith, Jonathan Serrano, Guomiao Shen, et al.
Neuro-Oncology Advances|July 21, 2023
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testingKristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2023
Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial MeningiomaSylvia C Kurz, Elcin Zan, Christine Cordova, et al.
Journal of Neurosurgery. Case Lessons|July 20, 2022
[68Ga]-DOTATATE PET/CT and PET/MRI in the diagnosis and management of esthesioneuroblastoma: illustrative casesMichelle Roytman, Andrew B Tassler, Ashutosh Kacker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2024
T2-FLAIR Mismatch Sign Predicts DNA Methylation Subclass and CDKN2A/B Status in IDH-Mutant AstrocytomasMatthew D Lee, Rajan Jain, Kristyn Galbraith, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 28, 2025
Neoadjuvant PD1 blockade with laser interstitial thermal therapy for recurrent high-grade gliomaCarter M Suryadevara, Hayley Donaldson, Hammad A Khan, et al.
BMC Genomics|June 1, 2012
Identification of chemosensory receptor genes in Manduca sexta and knockdown by RNA interferenceNatalie Howlett, Katherine L Dauber, Aditi Shukla, et al.
Neuro-Oncology|January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomasKristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
Molecular Cancer Research : MCR|October 23, 2023
Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain TumorsKristyn Galbraith, Jonathan Serrano, Guomiao Shen, et al.
Neuro-Oncology Advances|July 21, 2023
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testingKristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, et al.
Pageof 2